Resultados de búsqueda - Carlos Camps

Limitar resultados
  1. 1
    MicroRNAs: Promising New Antiangiogenic Targets in Cancer

    MicroRNAs: Promising New Antiangiogenic Targets in Cancer por Sandra Gallach, Silvia Calabuig‐Fariñas, Eloísa Jantus‐Lewintre, Carlos Camps

    Publicado 2014
    Enlace del recurso Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  2. 2
    Circulating tumor cells versus circulating tumor DNA in lung cancer—which one will win?

    Circulating tumor cells versus circulating tumor DNA in lung cancer—which one will win? por Silvia Calabuig‐Fariñas, Eloísa Jantus‐Lewintre, Alejandro Herreros‐Pomares, Carlos Camps

    Publicado 2016
    Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  3. 3
    Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer

    Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer por Anna Valentino, Pablo Reclusa, Rafael Sirera, Marco Giallombardo, Carlos Camps, Patrick Pauwels, Stefania Crispi, Christian Rolfo

    Publicado 2017
    Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  4. 4
    Individual Patient Data Meta-Analysis of Docetaxel Administered Once Every 3 Weeks Compared With Once Every Week Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer

    Individual Patient Data Meta-Analysis of Docetaxel Administered Once Every 3 Weeks Compared With Once Every Week Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer por Massimo Di Maïo, Francesco Perrone, Paolo Chiodini, Ciro Gallo, Carlos Camps, Wolfgang Schuette, Élisabeth Quoix, Chun-Ming Tsai, Cesare Gridelli

    Publicado 2007
    Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  5. 5
    microRNA-Associated Progression Pathways and Potential Therapeutic Targets Identified by Integrated mRNA and microRNA Expression Profiling in Breast Cancer

    microRNA-Associated Progression Pathways and Potential Therapeutic Targets Identified by Integrated mRNA and microRNA Expression Profiling in Breast Cancer por Francesca M. Buffa, Carlos Camps, Laura Winchester, Cameron Snell, Harriet E. Gee, Helen Sheldon, Marian Taylor, Adrian L. Harris, Jiannis Ragoussis

    Publicado 2011
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  6. 6
    The Role of Tumor Stroma in Cancer Progression and Prognosis: Emphasis on Carcinoma-Associated Fibroblasts and Non-small Cell Lung Cancer

    The Role of Tumor Stroma in Cancer Progression and Prognosis: Emphasis on Carcinoma-Associated Fibroblasts and Non-small Cell Lung Cancer por Roy M. Bremnes, Tom Dønnem, Samer Al‐Saad, Khalid Al‐Shibli, Sigve Andersen, Rafael Sirera, Carlos Camps, Inigo Marinez, Lill‐Tove Busund

    Publicado 2010
    Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  7. 7
    The Role of Tumor-Infiltrating Immune Cells and Chronic Inflammation at the Tumor Site on Cancer Development, Progression, and Prognosis: Emphasis on Non-small Cell Lung Cancer

    The Role of Tumor-Infiltrating Immune Cells and Chronic Inflammation at the Tumor Site on Cancer Development, Progression, and Prognosis: Emphasis on Non-small Cell Lung Cancer por Roy M. Bremnes, Khalid Al‐Shibli, Tom Dønnem, Rafael Sirera, Samer Al‐Saad, Sigve Andersen, Helge Stenvold, Carlos Camps, Lill‐Tove Busund

    Publicado 2010
    Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  8. 8
    Programmed Death-Ligand 1 (PD-L1) as Immunotherapy Biomarker in Breast Cancer

    Programmed Death-Ligand 1 (PD-L1) as Immunotherapy Biomarker in Breast Cancer por M. Nunez Abad, Silvia Calabuig‐Fariñas, M. Lobo de Mena, Susana Torres, Clara García González, José Ángel García, Vega Iranzo, Carlos Camps

    Publicado 2022
    Enlace del recurso Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  9. 9
    Ribonucleotide Reductase Messenger RNA Expression and Survival in Gemcitabine/Cisplatin-Treated Advanced Non-Small Cell Lung Cancer Patients

    Ribonucleotide Reductase Messenger RNA Expression and Survival in Gemcitabine/Cisplatin-Treated Advanced Non-Small Cell Lung Cancer Patients por Rafael Rosell, Kathleen D. Danenberg, V. Alberola, Gerold Bepler, José Javier Sánchez, Carlos Camps, Mariano Provencio, Dolores Isla, Miquel Tarón, Pilar Díz, Á. Artal

    Publicado 2004
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  10. 10
    Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro

    Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transi... por Lara Milián, Manuel Mata, Javier Alcácer, María Oliver-Ferrándiz, María Sancho‐Tello, José Javier Martı́n de Llano, Carlos Camps, José M. Galbis, Julián Carretero, Carmen Cardá

    Publicado 2020
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  11. 11
    Serum metabolomic profiling facilitates the non-invasive identification of metabolic biomarkers associated with the onset and progression of non-small cell lung cancer

    Serum metabolomic profiling facilitates the non-invasive identification of metabolic biomarkers associated with the onset and progression of non-small cell lung cancer por Leonor Puchades‐Carrasco, Eloísa Jantus‐Lewintre, Clara Pérez-Rambla, Francisco García‐García, Rut Lucas-Domínguez, Silvia Calabuig‐Fariñas, Ana Blasco, Joaquı́n Dopazo, Carlos Camps, Antonio Pineda‐Lucena

    Publicado 2016
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  12. 12
    Gene panel sequencing improves the diagnostic work-up of patients with idiopathic erythrocytosis and identifies new mutations

    Gene panel sequencing improves the diagnostic work-up of patients with idiopathic erythrocytosis and identifies new mutations por Carlos Camps, Nayia Petousi, Celeste Bento, Holger Cario, Richard R. Copley, Mary Frances McMullin, Richard van Wijk, Peter J. Ratcliffe, Peter A. Robbins, Jenny C. Taylor

    Publicado 2016
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  13. 13
    Refining the role of pegfilgrastim (a long-acting G-CSF) for prevention of chemotherapy-induced febrile neutropenia: consensus guidance recommendations

    Refining the role of pegfilgrastim (a long-acting G-CSF) for prevention of chemotherapy-induced febrile neutropenia: consensus guidance recommendations por Matti Aapro, Ralph V. Boccia, Robert Leonard, Carlos Camps, Mario Campone, Sylvain Choquet, Marco Danova, John A. Glaspy, Iwona Hus, Hartmut Link, Thamer Sliwa, Hans Tesch, Vicente Valero

    Publicado 2017
    Enlace del recurso Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  14. 14
    Update on systemic treatment in early triple negative breast cancer

    Update on systemic treatment in early triple negative breast cancer por M. Nunez Abad, Silvia Calabuig‐Fariñas, M. Lobo de Mena, María José Godes Sanz de Bremond, Clara García González, Susana Torres, José Ángel García, Vega Iranzo, Carlos Camps Herrero

    Publicado 2021
    Enlace del recurso Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  15. 15
    Circulating DNA is a Useful Prognostic Factor in Patients with Advanced Non-small Cell Lung Cancer

    Circulating DNA is a Useful Prognostic Factor in Patients with Advanced Non-small Cell Lung Cancer por Rafael Sirera, Roy M. Bremnes, Andrea Cabrera‐Pastor, Eloísa Jantus‐Lewintre, Elena Sanmartín, Ana Blasco, Nieves del Pozo, Rafael Rosell, Ricardo Guijarro, José M. Galbis, José Javier Sánchez, Carlos Camps

    Publicado 2011
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  16. 16
    The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis

    The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis por Harriet E. Gee, Francesca M. Buffa, Carlos Camps, Anassuya Ramachandran, Russell Leek, M Taylor, Meena Patil, Helen Sheldon, Guy Betts, Jarrod J. Homer, Catharine West, Jiannis Ragoussis, Adrian L. Harris

    Publicado 2011
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  17. 17
    Impact of DLK1-DIO3 imprinted cluster hypomethylation in smoker patients with lung cancer

    Impact of DLK1-DIO3 imprinted cluster hypomethylation in smoker patients with lung cancer por Sonia Molina‐Pinelo, Ana Salinas, Nicolás Moreno‐Mata, Irene Ferrer, Rocío Suárez, Eduardo Andrés‐León, Manuel Rodríguez‐Paredes, Julian Gutekunst, Eloísa Jantus‐Lewintre, Carlos Camps, Amancio Carnero, Luis Paz‐Ares

    Publicado 2016
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  18. 18
    Multicenter In-House Evaluation of an Amplicon-Based Next−Generation Sequencing Panel for Comprehensive Molecular Profiling

    Multicenter In-House Evaluation of an Amplicon-Based Next−Generation Sequencing Panel for Comprehensive Molecular Profiling por Eloísa Jantus‐Lewintre, Alessandra Rappa, Dina Ruano, Demi van Egmond, Sandra Gallach, Dilce Gozuyasli, Cecília Durães, José Luís Costa, Carlos Camps, Ludovic Lacroix, Karl Kashofer, Tom van Wezel, Massimo Barberis

    Publicado 2025
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  19. 19
    A Randomized Trial Comparing Preoperative Chemotherapy Plus Surgery with Surgery Alone in Patients with Non-Small-Cell Lung Cancer

    A Randomized Trial Comparing Preoperative Chemotherapy Plus Surgery with Surgery Alone in Patients with Non-Small-Cell Lung Cancer por R. Rosell, José Gómez‐Codina, Carlos Camps, J Maestre, Jose Padille, Antonio Cantó, José Luís Mate, Shanrong Li, Jorge Roig, Ángel Olazábal, Mercedes Canela, Aurelio Ariza, Z Skácel, Jose Morera-Prat, Albert Abad

    Publicado 1994
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  20. 20
    Analysis of the immune microenvironment in resected non-small cell lung cancer: the prognostic value of different T lymphocyte markers

    Analysis of the immune microenvironment in resected non-small cell lung cancer: the prognostic value of different T lymphocyte markers por Marta Usó, Eloísa Jantus‐Lewintre, Roy M. Bremnes, Silvia Calabuig‐Fariñas, Ana Blasco, Enrique Carbonell Pastor, Irene Borredá, Sonia Molina‐Pinelo, Luis Paz‐Ares, Ricardo Guijarro, Miguel Martorell, Jerónimo Forteza, Carlos Camps, Rafael Sirera

    Publicado 2016
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:

Herramientas de búsqueda: